A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
Duran I; Kortmansky J; Singh D; Hirte H; Kocha W; Goss G; Le L; Oza A; Nicklee T; Ho J; Birle D; Pond GR; Arboine D; Dancey J; Aviel-Ronen S; Tsao MS; Hedley D; Siu LL; British Journal Of Cancer, 2006, vol. 95, issue 9, p 1148, ISSN 00070920. ISBN 00070920.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef